Advertisement

Orbital Retinoblastoma: Diagnosis and Management

  • Bhavna Chawla
  • Maya Hada
Chapter

Abstract

Orbital retinoblastoma is a potentially fatal disease. It is more prevalent in the developing world where delay in presentation and lack of access to healthcare contribute to poor survival rates. However, with the evolution of a multimodal therapy, the prognosis for survival has improved significantly. The current treatment protocols use a combination of high-dose systemic chemotherapy, followed by appropriate surgery, radiotherapy, and adjuvant chemotherapy. This chapter discusses in detail the clinical spectrum of orbital retinoblastoma, classification and subtypes, evaluation and investigations, strategies for management, and future perspectives.

Keywords

Retinoblastoma Orbital Management 

References

  1. 1.
    Ellsworth RM. Orbital retinoblastoma. Trans Am Ophthalmol Soc. 1974;72:79–88.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Grabowski EF, Abramson DH. Intraocular and extra ocular retinoblastoma. Hematol Oncol Clin North Am. 1987;1:721–35.CrossRefGoogle Scholar
  3. 3.
    Kao LY, Su WW, Lin YW. Retinoblastoma in Taiwan: survival and clinical characteristics 1978-2000. Jpn J Ophthalmol. 2002;46:577–80.CrossRefGoogle Scholar
  4. 4.
    Badhu B, Sah SP, Thakur SK, et al. Clinical presentation of retinoblastoma in Eastern Nepal. Clin Exp Ophthalmol. 2005;33:386–9.CrossRefGoogle Scholar
  5. 5.
    Chawla B, Hasan F, Azad R, et al. Clinical presentation and survival of retinoblastoma in Indian children. Br J Ophthalmol. 2015;100:172–8.CrossRefGoogle Scholar
  6. 6.
    Leal-Leal C, Flores-Rojo M, Medina-Sansón A, et al. A multi-centre report from the Mexican retinoblastoma group. Br J Ophthalmol. 2004;88:1074–7.CrossRefGoogle Scholar
  7. 7.
    Magramm I, Abramson DH, Ellsworth RM. Optic nerve involvement in retinoblastoma. Ophthalmology. 1989;96:217–22.CrossRefGoogle Scholar
  8. 8.
    Rootman J, Ellsworth RM, Hofbauer J, et al. Orbital extension of retinoblastoma: a clinicopathological study. Can J Ophthalmol. 1978;13:72–80.PubMedGoogle Scholar
  9. 9.
    Stannard C, Lipper S, Sealy R, et al. Retinoblastoma: correlation of invasion of the optic nerve and choroid with prognosis and metastases. Br J Ophthalmol. 1979;63:560–70.CrossRefGoogle Scholar
  10. 10.
    Schvartzman E, Chantada G, Fandino A, et al. Results of a stage-based approach for the treatment of retinoblastoma. J Clin Oncol. 1996;14:1532–6.CrossRefGoogle Scholar
  11. 11.
    Finger PT, Harbour JW, Karcioglu ZA. Risk factors for metastasis in retinoblastoma. Surv Ophthalmol. 2002;47:1–16.CrossRefGoogle Scholar
  12. 12.
    Kopelman JE, McLean IW, Rosenberg SH. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology. 1987;94:371–7.CrossRefGoogle Scholar
  13. 13.
    Kauffman EC, Robinson VL, Stadler WM, et al. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site. J Urol. 2003;169:1122–33.CrossRefGoogle Scholar
  14. 14.
    Singh AD, Shields CL, Shields JA. Prognostic factors in retinoblastoma. J Pediatr Ophthalmol Strabismus. 2000;37:134–41.PubMedGoogle Scholar
  15. 15.
    Sanders BM, Draper GJ, Kingston JE. Retinoblastoma in Great Britain 1969-80: incidence, treatment, and survival. Br J Ophthalmol. 1988;72:576–83.Google Scholar
  16. 16.
    Chantada G, Doz F, Antoneli CB, et al. A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer. 2006;47:801–5.CrossRefGoogle Scholar
  17. 17.
    Chawla B, Kumar K, Singh AD. Influence of socioeconomic and cultural factors on retinoblastoma management. Asia Pac J Oncol Nurs. 2017;4:187–90.CrossRefGoogle Scholar
  18. 18.
    Shields JA, Shields CL. Intraocular tumours: a text and atlas. Philadelphia: WB Saunders; 1992.Google Scholar
  19. 19.
    Doz F, Khelfaoui F, Mosseri V, et al. The role of chemotherapy in orbital involvement of retinoblastoma. The experience of a single institution with 33 patients. Cancer. 1994;74:722–32.CrossRefGoogle Scholar
  20. 20.
    Antoneli CB, Steinhorst F, de Cássia Braga Ribeiro K, et al. Extraocular retinoblastoma: a 13-year experience. Cancer. 2003;98:1292–8.CrossRefGoogle Scholar
  21. 21.
    Menon BS, Reddy SC, Maziah WM, et al. Extraocular retinoblastoma. Med Pediatr Oncol. 2000;35:75–6.CrossRefGoogle Scholar
  22. 22.
    Honavar SG, Manjandavida FP, Reddy VP. Orbital retinoblastoma: an update. Indian J Ophthalmol. 2017;65:435–42.CrossRefGoogle Scholar
  23. 23.
    Chawla B, Seth R, Moksha L. Chemotherapy for ocular cancers. In: Pharmacology of ocular therapeutics. Cham: Springer International Publishing; 2016. p. 333–58.CrossRefGoogle Scholar
  24. 24.
    Amin MB, Edge SB, Greene FL, et al. Retinoblastoma. In: AJCC cancer staging manual, Ch. 68. 8th ed. New York: Springer; 2017. p. 819–31.CrossRefGoogle Scholar
  25. 25.
    Chawla B, Duraipandi K, Sharma S. MRI in retinoblastoma associated orbital cellulitis. Ophthalmology. 2013;120:1308–9.CrossRefGoogle Scholar
  26. 26.
    Hungerford J. Factors influencing metastasis in retinoblastoma. Br J Ophtalmol. 1993;77:541.CrossRefGoogle Scholar
  27. 27.
    Reese AB. Tumors of the eye. New York: Harper and Row; 1963. p. 155–6.Google Scholar
  28. 28.
    Chawla B, Hada M, Seth R, et al. Trabeculectomy in eyes with unsuspected retinoblastoma. Ophthalmic Genet. 2016;37:437–40.CrossRefGoogle Scholar
  29. 29.
    Vemuganti GK, Honavar SG, John R. Clinicopathological profile of retinoblastoma in Asian Indians. Invest Ophthalmol Vis Sci. 2000;41:790.Google Scholar
  30. 30.
    Chawla B, Sharma S, Sen S, et al. Correlation between clinical features, MRI and histopathologic findings in retinoblastoma: a prospective study. Ophthalmology. 2012;119:850–6.CrossRefGoogle Scholar
  31. 31.
    Kiratli PO, Kiratli H, Ercan MT. Visualization of orbital retinoblastoma with technetium-99m (V) dimercaptosuccinic acid. Ann Nucl Med. 1998;12:157–9.CrossRefGoogle Scholar
  32. 32.
    Moll AC, Hoekstra OS, Imhof SM, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography (PET) to detect vital retinoblastoma in the eye: preliminary experience. Ophthalmic Genet. 2004;25:31–5.CrossRefGoogle Scholar
  33. 33.
    Honavar SG, Singh AD. Management of advanced retinoblastoma. Ophthalmol Clin North Am. 2005;18:65–73.CrossRefGoogle Scholar
  34. 34.
    White L. Chemotherapy in retinoblastoma: current status and future directions. Am J Pediatr Hematol Oncol. 1991;13:189–201.CrossRefGoogle Scholar
  35. 35.
    Goble RR, McKenzie J, Kingston JE, et al. Orbital recurrence of retinoblastoma successfully treated by combined therapy. Br J Ophthalmol. 1990;74:97–8.CrossRefGoogle Scholar
  36. 36.
    Chawla B, Hasan F, Seth R, et al. Multimodal therapy for stage III retinoblastoma (International Retinoblastoma Staging System). Ophthalmology. 2016;123:1933–9.CrossRefGoogle Scholar
  37. 37.
    Chawla B, Khurana S, Sen S, et al. Clinical misdiagnosis of retinoblastoma in Indian children. Br J Ophthalmol. 2014;98:488–93.CrossRefGoogle Scholar
  38. 38.
    Kim JW, Kathpalia V, Dunkel IJ, et al. Orbital recurrence of retinoblastoma following enucleation. Br J Ophthalmol. 2009;93:463–7.CrossRefGoogle Scholar
  39. 39.
    Kremens B, Wieland R, Rienhart H, et al. High dose chemotherapy with autologous stem cell in children with retinoblastoma. Bone Marrow Transplant. 2003;31:281–4.CrossRefGoogle Scholar
  40. 40.
    Lee SH, Yoo KH, Sung KW, et al. Tandem high-dose chemotherapy and autologous stem cell rescue in children with bilateral advanced retinoblastoma. Bone Marrow Transplant. 2008;42:385–91.CrossRefGoogle Scholar
  41. 41.
    Munier FL, Verwey J, Pica A, et al. New developments in external beam radiotherapy in retinoblastoma from lens to normal tissue-sparing techniques. Clin Exp Ophthalmol. 2008;36:78–89.CrossRefGoogle Scholar
  42. 42.
    Maat-Kievit JA, Oepkes D, Hartwing NG. A large retinoblastoma detected in a fetus at 21 weeks of gestation. Prenat Diagn. 1993;13:377–84.CrossRefGoogle Scholar
  43. 43.
    Salim A, Wiknjosastro GH, Danukusumo D. Fetal retinoblastoma. J Ultrasound Med. 1998;17:717–20.CrossRefGoogle Scholar
  44. 44.
    Parsam VL, Kannabiran C, Honavar SG, et al. A comprehensive, sensitive and economical approach for the detection of mutations in RB1 gene in retinoblastoma. J Genet. 2009;88:517–27.CrossRefGoogle Scholar
  45. 45.
    Chawla B, Singh R. Recent advances and challenges in the management of retinoblastoma. Ind J Ophthalmol. 2017;65:133–9.CrossRefGoogle Scholar
  46. 46.
    Wolff JA, Boesel C, Ellsworth RM, et al. Children’s Cancer Study Group Protocol CCSG 962. New York: Childrens Cancer Group; 1978.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Bhavna Chawla
    • 1
  • Maya Hada
    • 2
  1. 1.Ocular Oncology Service Dr. Rajendra Prasad Centre for Ophthalmic SciencesNew DelhiIndia
  2. 2.Department of OphthalmologySMS Medical College & HospitalJaipurIndia

Personalised recommendations